RCL1 copy number variants are associated with a range of neuropsychiatric phenotypes

Autor: Casie A. Genetti, Ferne Pinard, Abhijit S. Rao, Emily A. Garvey, Stephen W. Scherer, Christopher A. Walsh, Dimitri J. Stavropoulos, Mehdi Zarrei, Adam W. Hansen, Eugene J. D'Angelo, Emma A. Deaso, Annmarie Caracansi, Jill A. Rosenfeld, Hesham M. Hamoda, Richard S. Smith, Mark P. Gorman, Alan H. Beggs, Jianqiao Li, Richard A. Gibbs, Devon Carroll, Catherine A. Brownstein, Joseph Gonzalez-Heydrich, Jennifer L. Howe, David C. Glahn, Margaret A. Hojlo, Lance H. Rodan, Pankaj B. Agrawal, Joshua J. Bowen, Kristin Cabral, Weimin Bi
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Molecular Psychiatry
ISSN: 1476-5578
1359-4184
Popis: Mendelian and early-onset severe psychiatric phenotypes often involve genetic variants having a large effect, offering opportunities for genetic discoveries and early therapeutic interventions. Here, the index case is an 18-year-old boy, who at 14 years of age had a decline in cognitive functioning over the course of a year and subsequently presented with catatonia, auditory and visual hallucinations, paranoia, aggression, mood dysregulation, and disorganized thoughts. Exome sequencing revealed a stop-gain mutation in RCL1 (NM_005772.4:c.370 C > T, p.Gln124Ter), encoding an RNA 3′-terminal phosphate cyclase-like protein that is highly conserved across eukaryotic species. Subsequent investigations across two academic medical centers identified eleven additional cases of RCL1 copy number variations (CNVs) with varying neurodevelopmental or psychiatric phenotypes. These findings suggest that dosage variation of RCL1 contributes to a range of neurological and clinical phenotypes.
Databáze: OpenAIRE